Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01510353 · ClinicalTrials.gov registry record · Phase 3
Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization
A Phase 3 study of Radiation Protection and Radiation Monitoring, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- Phase 3
- Development phase
- 505
- Enrollment target
- 1
- Study location
NCT01510353: Completed Phase 3 study of Radiation Protection and Radiation Monitoring, sponsored by North Texas Veterans Healthcare System.
NCT01510353 is a Phase 3 study of Radiation Protection and Radiation Monitoring that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 505 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01510353, a Phase 3 study of Radiation Protection and Radiation Monitoring, has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 505 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the impact of using a real time radiation exposure monitoring device on the patient and operator radiation exposure during cardiac catheterization. The hypothesis of the study is that use of a real time radiation exposure monitoring device during cardiac catheterization will decrease both patient and operator radiation exposure compared to no use of the monitoring device.
Primary Outcome
Radiation exposure of the operator (measured in mrem by the real time monitoring device)
Conditions Studied
Interventions
- DEVICE Radiation monitoring device
Study Locations (1)
Texas
- VA North Texas Health Care System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 505 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-05 |
| Phase | Phase 3 |
What the finished NCT01510353 record still lists
NCT01510353 is an interventional study that assigns participants to a tested intervention. The registered 505 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (35% lower).
The record links to 2 conditions, with Radiation Protection appearing as the primary indexed condition, and to 1 intervention - of which Radiation monitoring device is the first listed.
NCT01510353 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01510353 about?
NCT01510353 is a clinical study titled "Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac Catheterization". The purpose of this study is to examine the impact of using a real time radiation exposure monitoring device on the patient and operator radiation exposure during cardiac catheterization. The hypothesis of the study is that use of a real time radiation exposure monitoring device during cardiac cathe...
What is the current status of trial NCT01510353?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 505 participants. The study started on 2012-01. Estimated completion is 2014-05.
What conditions does trial NCT01510353 study?
This clinical trial studies the following conditions: Radiation Protection, Radiation Monitoring.
What interventions are being tested in trial NCT01510353?
The interventions under investigation include: Radiation monitoring device (DEVICE).
Who is sponsoring clinical trial NCT01510353?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01510353 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Protection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01510353's enrollment target sits among peer trials
505 742nd of 2000 higher than 1,259 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05069428 · 506 participants · Phase 4
Delirium Reduction With Ramelteon
- NCT05797168 · 506 participants · Phase 1
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- NCT05846282 · 504 participants · NA
Students Rising Above: Offsetting the Health and Mental Health Costs of Resilience
- NCT06072131 · 504 participants · Phase 3
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia